Cargando…

Correction: Improvement of a Predictive Model of Castration-Resistant Prostate Cancer: Functional Genetic Variants in TGFβ1 Signaling Pathway Modulation

Detalles Bibliográficos
Autores principales:	Teixeira, Ana L., Gomes, Mónica, Nogueira, Augusto, Azevedo, Andreia S., Assis, Joana, Dias, Francisca, Santos, Juliana I., Lobo, Francisco, Morais, António, Maurício, Joaquina, Medeiros, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752013/ http://dx.doi.org/10.1371/annotation/47bdb3be-4110-48de-a29d-e4734e64f6a0

Ejemplares similares

Improvement of a Predictive Model of Castration-Resistant Prostate Cancer: Functional Genetic Variants in TGFβ1 Signaling Pathway Modulation
por: Teixeira, Ana L., et al.
Publicado: (2013)

Combined Influence of EGF+61G>A and TGFB+869T>C Functional Polymorphisms in Renal Cell Carcinoma Progression and Overall Survival: The Link to Plasma Circulating MiR-7 and MiR-221/222 Expression
por: Teixeira, Ana L., et al.
Publicado: (2015)

Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends
por: Figueiredo, Arnaldo, et al.
Publicado: (2022)

Correction to: Nonmetastatic Castration‑Resistant Prostate Cancer: Current Challenges and Trends
por: Figueiredo, Arnaldo, et al.
Publicado: (2022)

Correction to: Nonmetastatic Castration‑Resistant Prostate Cancer: Current Challenges and Trends
por: Figueiredo, Arnaldo, et al.
Publicado: (2023)

Extracellular Vesicles Enriched in hsa-miR-301a-3p and hsa-miR-1293 Dynamics in Clear Cell Renal Cell Carcinoma Patients: Potential Biomarkers of Metastatic Disease
por: Dias, Francisca, et al.
Publicado: (2020)

Plasmatic miR-210, miR-221 and miR-1233 profile: potential liquid biopsies candidates for renal cell carcinoma
por: Dias, Francisca, et al.
Publicado: (2017)

Plasma Extracellular Vesicle-Derived TIMP-1 mRNA as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma: A Pilot Study
por: Dias, Francisca, et al.
Publicado: (2020)

Metastatic Castration-Resistant Prostate Cancer with BRCA2 Mutation: The Challenge Incorporating PARP Inhibitors and Platinum in Treatment Sequencing
por: Nogueira Costa, Inês, et al.
Publicado: (2022)

Metastatic castration-resistant prostate cancer and the challenge of a patient with chronic kidney disease in hemodialysis
por: Simões, Joana, et al.
Publicado: (2018)

Castration for Prostatic Hypertrophy
Publicado: (1899)

Involving the microRNA Targetome in Esophageal-Cancer Development and Behavior
por: Dias, Francisca, et al.
Publicado: (2018)

Telomere Length in Renal Cell Carcinoma: The Jekyll and Hyde Biomarker of Ageing of the Kidney
por: Morais, Mariana, et al.
Publicado: (2020)

Circulating biomarkers in renal cell carcinoma: the link between microRNAs and extracellular vesicles, where are we now?
por: Teixeira, Ana L, et al.
Publicado: (2014)

Prostatic Neoplasia in the Intact and Castrated Dog: How Dangerous is Castration?
por: Schrank, Magdalena, et al.
Publicado: (2020)

Androgen Receptor Variants Occur Frequently in Castration Resistant Prostate Cancer Metastases
por: Zhang, Xiaotun, et al.
Publicado: (2011)

A Compendium of AR Splice Variants in Metastatic Castration-Resistant Prostate Cancer
por: Isebia, Khrystany T., et al.
Publicado: (2023)

Castration for Hypertrophy of the Prostate Gland
Publicado: (1895)

LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer Progression
por: Dias, Francisca, et al.
Publicado: (2021)

Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management
por: Almeida, Cristina, et al.
Publicado: (2023)

“Prostate telocytes change their phenotype in response to castration or testosterone replacement”
por: Felisbino, Sérgio Luis, et al.
Publicado: (2019)

Androgen receptor variant-7: an important predictive biomarker in castrate resistant prostate cancer
por: Sartor, Oliver, et al.
Publicado: (2015)

Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
por: Sharp, Adam, et al.
Publicado: (2018)

Plasmatic MicroRNAs and Treatment Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer: A Hospital-Based Cohort Study and In Silico Analysis
por: Silva, Jani, et al.
Publicado: (2023)

Starch-Capped AgNPs’ as Potential Cytotoxic Agents against Prostate Cancer Cells
por: Morais, Mariana, et al.
Publicado: (2021)

Optimizing the treatment of metastatic castration-resistant prostate cancer: a Latin America perspective
por: Sade, Juan Pablo, et al.
Publicado: (2018)

Utilization and Outcomes of Surgical Castration in Comparison to Medical Castration in Metastatic Prostate Cancer
por: Garje, Rohan, et al.
Publicado: (2019)

Nonmetastatic Castration-Resistant Prostate Cancer
por: Hong, Jun Hyuk, et al.
Publicado: (2014)

Darolutamide For Castration-Resistant Prostate Cancer
por: Bastos, Diogo A, et al.
Publicado: (2019)

A Case of Castration for Hypertrophied Prostate
Publicado: (1897)

SAT-327 Targeting FOXA1-mediated Repression of TGF-B Signaling Supresses Castration-Resistant Prostate Cancer Progression
por: Park, Su Hong (Kevin)
Publicado: (2019)

FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer
por: Jones, Dominic, et al.
Publicado: (2015)

Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer
por: von Amsberg, Gunhild, et al.
Publicado: (2022)

Androgen Receptor Variants Confer Castration Resistance in Prostate Cancer by Counteracting Antiandrogen-Induced Ferroptosis
por: Sun, Rui, et al.
Publicado: (2023)

Cancer Cells’ Metabolism Dynamics in Renal Cell Carcinoma Patients’ Outcome: Influence of GLUT-1-Related hsa-miR-144 and hsa-miR-186
por: Morais, Mariana, et al.
Publicado: (2021)

Glucose-Functionalized Silver Nanoparticles as a Potential New Therapy Agent Targeting Hormone-Resistant Prostate Cancer cells
por: Morais, Mariana, et al.
Publicado: (2022)

Claudin-3 Loss of Expression Is a Prognostic Marker in Castration-Resistant Prostate Cancer
por: Orea, María J., et al.
Publicado: (2023)

Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
por: Mai, Lixin, et al.
Publicado: (2020)

Antitumor Effect of Chalcone Derivatives against Human Prostate (LNCaP and PC-3), Cervix HPV-Positive (HeLa) and Lymphocyte (Jurkat) Cell Lines and Their Effect on Macrophage Functions
por: Horta, Bruno, et al.
Publicado: (2023)

The Effects of Castration and Stilboestrol on Prostatic Tumours in Mice
por: Horning, E. S.
Publicado: (1949)

Cannot write session to /tmp/vufind_sessions/sess_eeolmbh7tp8292qet3smk4tis1